Comparing Adjuvant Clindamycin to Linezolid for Invasive Group A Streptococcal Infections

Scott, Jake MD

Clinical Assistant Professor, Infectious Diseases and Geographic Medicine, Stanford University School of Medicine; Antimicrobial Stewardship Program Medical Director, Stanford Health Care Tri-Valley

Infectious Disease Alert 43(4):p 42-44, January 2024.

SYNOPSIS: In a retrospective, single-center cohort study of patients with severe group A streptococcal infection, there was no significant difference in clinical response in those treated with adjunctive clindamycin as compared with adjunctive linezolid.

SOURCE: Heil EL, Kaur H, Atalla A, et al. Comparison of adjuvant clindamycin versus linezolid for severe invasive group A streptococcal skin and soft tissue infections. Open Forum Infect Dis 2023; Nov 24:ofad588.